These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19116449)

  • 1. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells.
    Kim TY; Kim IS; Jong HS; Lee JW; Kim TY; Jung M; Bang YJ
    Exp Mol Med; 2008 Dec; 40(6):639-46. PubMed ID: 19116449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
    Choi HS; Lee JH; Park JG; Lee YI
    Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.
    Kumar P; Tripathi S; Pandey KN
    J Biol Chem; 2014 Mar; 289(10):6991-7002. PubMed ID: 24451378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
    Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
    Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
    Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
    J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
    Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
    Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor.
    Xiao H; Hasegawa T; Isobe K
    J Biol Chem; 2000 Jan; 275(2):1371-6. PubMed ID: 10625687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes.
    Schnur N; Seuter S; Katryniok C; Rådmark O; Steinhilber D
    Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins.
    Camolotto SA; Racca AC; Ridano ME; Genti-Raimondi S; Panzetta-Dutari GM
    PLoS One; 2013; 8(2):e55992. PubMed ID: 23418492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells.
    Mishra DR; Chaudhary S; Krishna BM; Mishra SK
    PLoS One; 2015; 10(4):e0124864. PubMed ID: 25923237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
    Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA
    Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
    Xiao H; Hasegawa T; Isobe K
    J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP28 gene expression is regulated by Sp1 transcription factor acetylation.
    Swingler TE; Kevorkian L; Culley KL; Illman SA; Young DA; Parker AE; Lohi J; Clark IM
    Biochem J; 2010 Apr; 427(3):391-400. PubMed ID: 20144149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of trichostatin A on neuronal mu-opioid receptor gene expression.
    Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL
    Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A stimulates steroid 5alpha-reductase gene expression in rat C6 glioma cells via a mechanism involving Sp1 and Sp3 transcription factors.
    Her S; Lee MS; Morita K
    J Mol Neurosci; 2010 Jun; 41(2):252-62. PubMed ID: 19728174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.